cimadronate has been researched along with cloprostenol in 1 studies
| Studies (cimadronate) | Trials (cimadronate) | Recent Studies (post-2010) (cimadronate) | Studies (cloprostenol) | Trials (cloprostenol) | Recent Studies (post-2010) (cloprostenol) |
|---|---|---|---|---|---|
| 105 | 3 | 4 | 1,365 | 357 | 357 |
| Protein | Taxonomy | cimadronate (IC50) | cloprostenol (IC50) |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | Bos taurus (cattle) | 0.001 | |
| Prostaglandin G/H synthase 2 | Bos taurus (cattle) | 0.001 | |
| Prostaglandin E2 receptor EP1 subtype | Homo sapiens (human) | 0.496 | |
| Prostaglandin F2-alpha receptor | Homo sapiens (human) | 0.0015 | |
| Prostaglandin E2 receptor EP3 subtype | Homo sapiens (human) | 0.635 | |
| Prostaglandin E2 receptor EP2 subtype | Homo sapiens (human) | 3.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harada, A; Hirade, K; Ito, H; Kato, K; Kozawa, O; Matsuno, H; Oiso, Y; Tokuda, H | 1 |
1 other study(ies) available for cimadronate and cloprostenol
| Article | Year |
|---|---|
Incadronate amplifies prostaglandin F2 alpha-induced vascular endothelial growth factor synthesis in osteoblasts. Enhancement of MAPK activity.
Topics: Alkyl and Aryl Transferases; Animals; Cell Line; Cloprostenol; Cycloheximide; Cyclooxygenase Inhibitors; Dinoprost; Diphosphonates; Endothelial Growth Factors; Enzyme Activation; Enzyme Inhibitors; Farnesyltranstransferase; Flavonoids; Gene Expression; Indoles; Indomethacin; Intercellular Signaling Peptides and Proteins; Lymphokines; Maleimides; Mice; Osteoblasts; Prostaglandins F, Synthetic; Protein Kinase C; RNA, Messenger; Sodium Fluoride; Tetradecanoylphorbol Acetate; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |